APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Nutraceutical

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Oral Nutraceutical Market Outlook and Growth Opportunities 2026

30 December 2025200 pages

Choose your research edition.

Industry ResearchOral Nutraceutical Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Nutraceutical Industry Growth and Trends Forecast to 2032123 pages · $3,450 USDMarket StructureGlobal Oral Nutraceutical Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Nutraceutical Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Nutraceutical Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Oral Nutraceutical market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Oral Nutraceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Oral Nutraceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Nutraceutical is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Oral Nutraceutical market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Oral Nutraceutical market include DSM, Barilla Group, Freedom Food Group Limited, Glanbia, Hero Group, Kerry Group, Nature’s Bounty, Raisio Group and Archer Daniels Midland, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Oral Nutraceutical market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Oral Nutraceutical and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Oral Nutraceutical revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Oral Nutraceutical market.

Oral Nutraceutical Segment by Company

DSM

Barilla Group

Freedom Food Group Limited

Glanbia

Hero Group

Kerry Group

Nature’s Bounty

Raisio Group

Archer Daniels Midland

Amway

BASF

DuPont

Fonterra

Kellogg's

Cargill

Conagra

Nestlé

Tate & Lyle

General Mills

Ingredion

Oral Nutraceutical Segment by Type

Oral Solid Dosage Forms

Oral Liquid Dosage Forms

Oral Nutraceutical Segment by Application

Home Use

Hospital Use

Oral Nutraceutical Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Oral Nutraceutical status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Oral Nutraceutical key companies, revenue, market share, and recent developments.

3. To split the Oral Nutraceutical breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Oral Nutraceutical market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Oral Nutraceutical significant trends, drivers, influence factors in global and regions.

6. To analyze Oral Nutraceutical competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Nutraceutical market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Nutraceutical and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Nutraceutical.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Oral Nutraceutical industry.

Chapter 3: Detailed analysis of Oral Nutraceutical company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Oral Nutraceutical in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Oral Nutraceutical in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Oral Nutraceutical Industry Trends Table 2. Oral Nutraceutical Industry Drivers Table 3. Oral Nutraceutical Industry Opportunities and Challenges Table 4. Oral Nutraceutical Industry Restraints Table 5. Global Oral Nutraceutical Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Oral Nutraceutical Revenue Share by Company (2021-2026) Table 7. Global Oral Nutraceutical Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Oral Nutraceutical Key Company Manufacturing Base & Headquarters Table 9. Global Oral Nutraceutical Company, Product Type & Application Table 10. Global Oral Nutraceutical Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Oral Nutraceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Oral Solid Dosage Forms Table 15. Significant Companies of Oral Liquid Dosage Forms Table 16. Global Oral Nutraceutical Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Oral Nutraceutical Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Oral Nutraceutical Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Oral Nutraceutical Sales Value Share by Type (2021-2026) Table 20. Global Oral Nutraceutical Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Home Use Table 22. Significant Companies of Hospital Use Table 23. Global Oral Nutraceutical Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Oral Nutraceutical Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Oral Nutraceutical Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Oral Nutraceutical Sales Value Share by Application (2021-2026) Table 27. Global Oral Nutraceutical Sales Value Share by Application (2027-2032) Table 28. Global Oral Nutraceutical Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Oral Nutraceutical Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Oral Nutraceutical Sales Value Share by Region (2021-2026) Table 31. Global Oral Nutraceutical Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Oral Nutraceutical Sales Value Share by Region (2027-2032) Table 33. Global Oral Nutraceutical Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Oral Nutraceutical Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Oral Nutraceutical Sales Value Market Share by Country (2021-2026) Table 36. Global Oral Nutraceutical Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Oral Nutraceutical Sales Value Market Share by Country (2027-2032) Table 38. DSM Company Information Table 39. DSM Business Overview Table 40. DSM Oral Nutraceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. DSM Oral Nutraceutical Product Portfolio Table 42. DSM Recent Development Table 43. Barilla Group Company Information Table 44. Barilla Group Business Overview Table 45. Barilla Group Oral Nutraceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Barilla Group Oral Nutraceutical Product Portfolio Table 47. Barilla Group Recent Development Table 48. Freedom Food Group Limited Company Information Table 49. Freedom Food Group Limited Business Overview Table 50. Freedom Food Group Limited Oral Nutraceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Freedom Food Group Limited Oral Nutraceutical Product Portfolio Table 52. Freedom Food Group Limited Recent Development Table 53. Glanbia Company Information Table 54. Glanbia Business Overview Table 55. Glanbia Oral Nutraceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Glanbia Oral Nutraceutical Product Portfolio Table 57. Glanbia Recent Development Table 58. Hero Group Company Information Table 59. Hero Group Business Overview Table 60. Hero Group Oral Nutraceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Hero Group Oral Nutraceutical Product Portfolio Table 62. Hero Group Recent Development Table 63. Kerry Group Company Information Table 64. Kerry Group Business Overview Table 65. Kerry Group Oral Nutraceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Kerry Group Oral Nutraceutical Product Portfolio Table 67. Kerry Group Recent Development Table 68. Nature’s Bounty Company Information Table 69. Nature’s Bounty Business Overview Table 70. Nature’s Bounty Oral Nutraceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Nature’s Bounty Oral Nutraceutical Product Portfolio Table 72. Nature’s Bounty Recent Development Table 73. Raisio Group Company Information Table 74. Raisio Group Business Overview Table 75. Raisio Group Oral Nutraceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Raisio Group Oral Nutraceutical Product Portfolio Table 77. Raisio Group Recent Development Table 78. Archer Daniels Midland Company Information Table 79. Archer Daniels Midland Business Overview Table 80. Archer Daniels Midland Oral Nutraceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Archer Daniels Midland Oral Nutraceutical Product Portfolio Table 82. Archer Daniels Midland Recent Development Table 83. Amway Company Information Table 84. Amway Business Overview Table 85. Amway Oral Nutraceutical Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Amway Oral Nutraceutical Product Portfolio Table 87. Amway Recent Development Table 88. BASF Company Information Table 89. BASF Business Overview Table 90. BASF Oral Nutraceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. BASF Oral Nutraceutical Product Portfolio Table 92. BASF Recent Development Table 93. DuPont Company Information Table 94. DuPont Business Overview Table 95. DuPont Oral Nutraceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. DuPont Oral Nutraceutical Product Portfolio Table 97. DuPont Recent Development Table 98. Fonterra Company Information Table 99. Fonterra Business Overview Table 100. Fonterra Oral Nutraceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Fonterra Oral Nutraceutical Product Portfolio Table 102. Fonterra Recent Development Table 103. Kellogg's Company Information Table 104. Kellogg's Business Overview Table 105. Kellogg's Oral Nutraceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Kellogg's Oral Nutraceutical Product Portfolio Table 107. Kellogg's Recent Development Table 108. Cargill Company Information Table 109. Cargill Business Overview Table 110. Cargill Oral Nutraceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Cargill Oral Nutraceutical Product Portfolio Table 112. Cargill Recent Development Table 113. Conagra Company Information Table 114. Conagra Business Overview Table 115. Conagra Oral Nutraceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Conagra Oral Nutraceutical Product Portfolio Table 117. Conagra Recent Development Table 118. Nestlé Company Information Table 119. Nestlé Business Overview Table 120. Nestlé Oral Nutraceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Nestlé Oral Nutraceutical Product Portfolio Table 122. Nestlé Recent Development Table 123. Tate & Lyle Company Information Table 124. Tate & Lyle Business Overview Table 125. Tate & Lyle Oral Nutraceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Tate & Lyle Oral Nutraceutical Product Portfolio Table 127. Tate & Lyle Recent Development Table 128. General Mills Company Information Table 129. General Mills Business Overview Table 130. General Mills Oral Nutraceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 131. General Mills Oral Nutraceutical Product Portfolio Table 132. General Mills Recent Development Table 133. Ingredion Company Information Table 134. Ingredion Business Overview Table 135. Ingredion Oral Nutraceutical Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 136. Ingredion Oral Nutraceutical Product Portfolio Table 137. Ingredion Recent Development Table 138. Research Programs/Design for This Report Table 139. Authors List of This Report Table 140. Secondary Sources Table 141. Primary Sources List of Figures Figure 1. Oral Nutraceutical Product Image Figure 2. Global Oral Nutraceutical Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Nutraceutical Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral Nutraceutical Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Oral Solid Dosage Forms Image Figure 8. Oral Liquid Dosage Forms Image Figure 9. Global Oral Nutraceutical Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Oral Nutraceutical Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Oral Nutraceutical Sales Value Share by Type (2021-2032) Figure 12. Home Use Image Figure 13. Hospital Use Image Figure 14. Global Oral Nutraceutical Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Oral Nutraceutical Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Oral Nutraceutical Sales Value Share by Application (2021-2032) Figure 17. Global Oral Nutraceutical Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Oral Nutraceutical Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Oral Nutraceutical Sales Value (2021-2032) & (US$ Million) Figure 20. North America Oral Nutraceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Oral Nutraceutical Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Oral Nutraceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Oral Nutraceutical Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Oral Nutraceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Oral Nutraceutical Sales Value (2021-2032) & (US$ Million) Figure 26. South America Oral Nutraceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Oral Nutraceutical Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Oral Nutraceutical Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Oral Nutraceutical Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Solid Dosage Forms
  • Oral Liquid Dosage Forms
Applications
  • Home Use
  • Hospital Use
Companies covered
  • DSM
  • Barilla Group
  • Freedom Food Group Limited
  • Glanbia
  • Hero Group
  • Kerry Group
  • Nature’s Bounty
  • Raisio Group
  • Archer Daniels Midland
  • Amway
  • BASF
  • DuPont
  • Fonterra
  • Kellogg's
  • Cargill
  • Conagra
  • Nestlé
  • Tate & Lyle
  • General Mills
  • Ingredion

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Oral Nutraceutical Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Oral Nutraceutical Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Oral Nutraceutical Market Dynamics
  1. 2.1 Oral Nutraceutical Industry Trends
  2. 2.2 Oral Nutraceutical Industry Drivers
  3. 2.3 Oral Nutraceutical Industry Opportunities and Challenges
  4. 2.4 Oral Nutraceutical Industry Restraints
3 Oral Nutraceutical Market by Company
  1. 3.1 Global Oral Nutraceutical Company Revenue Ranking in 2025
  2. 3.2 Global Oral Nutraceutical Revenue by Company (2021-2026)
  3. 3.3 Global Oral Nutraceutical Company Ranking (2024-2026)
  4. 3.4 Global Oral Nutraceutical Company Manufacturing Base and Headquarters
  5. 3.5 Global Oral Nutraceutical Company Product Type and Application
  6. 3.6 Global Oral Nutraceutical Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Oral Nutraceutical Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Oral Nutraceutical Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Oral Nutraceutical Market by Type
  1. 4.1 Oral Nutraceutical Type Introduction
  2. 4.1.1 Oral Solid Dosage Forms
  3. 4.1.2 Oral Liquid Dosage Forms
  4. 4.2 Global Oral Nutraceutical Sales Value by Type
  5. 4.2.1 Global Oral Nutraceutical Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Oral Nutraceutical Sales Value by Type (2021-2032)
  7. 4.2.3 Global Oral Nutraceutical Sales Value Share by Type (2021-2032)
5 Oral Nutraceutical Market by Application
  1. 5.1 Oral Nutraceutical Application Introduction
  2. 5.1.1 Home Use
  3. 5.1.2 Hospital Use
  4. 5.2 Global Oral Nutraceutical Sales Value by Application
  5. 5.2.1 Global Oral Nutraceutical Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Oral Nutraceutical Sales Value by Application (2021-2032)
  7. 5.2.3 Global Oral Nutraceutical Sales Value Share by Application (2021-2032)
6 Oral Nutraceutical Regional Value Analysis
  1. 6.1 Global Oral Nutraceutical Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Oral Nutraceutical Sales Value by Region (2021-2032)
  3. 6.2.1 Global Oral Nutraceutical Sales Value by Region: 2021-2026
  4. 6.2.2 Global Oral Nutraceutical Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Oral Nutraceutical Sales Value (2021-2032)
  7. 6.3.2 North America Oral Nutraceutical Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Oral Nutraceutical Sales Value (2021-2032)
  10. 6.4.2 Europe Oral Nutraceutical Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Oral Nutraceutical Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Oral Nutraceutical Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Oral Nutraceutical Sales Value (2021-2032)
  16. 6.6.2 South America Oral Nutraceutical Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Oral Nutraceutical Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Oral Nutraceutical Sales Value Share by Country, 2025 VS 2032
7 Oral Nutraceutical Country-level Value Analysis
  1. 7.1 Global Oral Nutraceutical Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Oral Nutraceutical Sales Value by Country (2021-2032)
  3. 7.2.1 Global Oral Nutraceutical Sales Value by Country (2021-2026)
  4. 7.2.2 Global Oral Nutraceutical Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Oral Nutraceutical Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Oral Nutraceutical Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Oral Nutraceutical Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 DSM
  2. 8.1.1 DSM Company Information
  3. 8.1.2 DSM Business Overview
  4. 8.1.3 DSM Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  5. 8.1.4 DSM Oral Nutraceutical Product Portfolio
  6. 8.1.5 DSM Recent Developments
  7. 8.2 Barilla Group
  8. 8.2.1 Barilla Group Company Information
  9. 8.2.2 Barilla Group Business Overview
  10. 8.2.3 Barilla Group Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Barilla Group Oral Nutraceutical Product Portfolio
  12. 8.2.5 Barilla Group Recent Developments
  13. 8.3 Freedom Food Group Limited
  14. 8.3.1 Freedom Food Group Limited Company Information
  15. 8.3.2 Freedom Food Group Limited Business Overview
  16. 8.3.3 Freedom Food Group Limited Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Freedom Food Group Limited Oral Nutraceutical Product Portfolio
  18. 8.3.5 Freedom Food Group Limited Recent Developments
  19. 8.4 Glanbia
  20. 8.4.1 Glanbia Company Information
  21. 8.4.2 Glanbia Business Overview
  22. 8.4.3 Glanbia Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Glanbia Oral Nutraceutical Product Portfolio
  24. 8.4.5 Glanbia Recent Developments
  25. 8.5 Hero Group
  26. 8.5.1 Hero Group Company Information
  27. 8.5.2 Hero Group Business Overview
  28. 8.5.3 Hero Group Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Hero Group Oral Nutraceutical Product Portfolio
  30. 8.5.5 Hero Group Recent Developments
  31. 8.6 Kerry Group
  32. 8.6.1 Kerry Group Company Information
  33. 8.6.2 Kerry Group Business Overview
  34. 8.6.3 Kerry Group Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Kerry Group Oral Nutraceutical Product Portfolio
  36. 8.6.5 Kerry Group Recent Developments
  37. 8.7 Nature’s Bounty
  38. 8.7.1 Nature’s Bounty Company Information
  39. 8.7.2 Nature’s Bounty Business Overview
  40. 8.7.3 Nature’s Bounty Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Nature’s Bounty Oral Nutraceutical Product Portfolio
  42. 8.7.5 Nature’s Bounty Recent Developments
  43. 8.8 Raisio Group
  44. 8.8.1 Raisio Group Company Information
  45. 8.8.2 Raisio Group Business Overview
  46. 8.8.3 Raisio Group Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Raisio Group Oral Nutraceutical Product Portfolio
  48. 8.8.5 Raisio Group Recent Developments
  49. 8.9 Archer Daniels Midland
  50. 8.9.1 Archer Daniels Midland Company Information
  51. 8.9.2 Archer Daniels Midland Business Overview
  52. 8.9.3 Archer Daniels Midland Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Archer Daniels Midland Oral Nutraceutical Product Portfolio
  54. 8.9.5 Archer Daniels Midland Recent Developments
  55. 8.10 Amway
  56. 8.10.1 Amway Company Information
  57. 8.10.2 Amway Business Overview
  58. 8.10.3 Amway Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Amway Oral Nutraceutical Product Portfolio
  60. 8.10.5 Amway Recent Developments
  61. 8.11 BASF
  62. 8.11.1 BASF Company Information
  63. 8.11.2 BASF Business Overview
  64. 8.11.3 BASF Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  65. 8.11.4 BASF Oral Nutraceutical Product Portfolio
  66. 8.11.5 BASF Recent Developments
  67. 8.12 DuPont
  68. 8.12.1 DuPont Company Information
  69. 8.12.2 DuPont Business Overview
  70. 8.12.3 DuPont Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  71. 8.12.4 DuPont Oral Nutraceutical Product Portfolio
  72. 8.12.5 DuPont Recent Developments
  73. 8.13 Fonterra
  74. 8.13.1 Fonterra Company Information
  75. 8.13.2 Fonterra Business Overview
  76. 8.13.3 Fonterra Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Fonterra Oral Nutraceutical Product Portfolio
  78. 8.13.5 Fonterra Recent Developments
  79. 8.14 Kellogg's
  80. 8.14.1 Kellogg's Company Information
  81. 8.14.2 Kellogg's Business Overview
  82. 8.14.3 Kellogg's Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Kellogg's Oral Nutraceutical Product Portfolio
  84. 8.14.5 Kellogg's Recent Developments
  85. 8.15 Cargill
  86. 8.15.1 Cargill Company Information
  87. 8.15.2 Cargill Business Overview
  88. 8.15.3 Cargill Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Cargill Oral Nutraceutical Product Portfolio
  90. 8.15.5 Cargill Recent Developments
  91. 8.16 Conagra
  92. 8.16.1 Conagra Company Information
  93. 8.16.2 Conagra Business Overview
  94. 8.16.3 Conagra Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Conagra Oral Nutraceutical Product Portfolio
  96. 8.16.5 Conagra Recent Developments
  97. 8.17 Nestlé
  98. 8.17.1 Nestlé Company Information
  99. 8.17.2 Nestlé Business Overview
  100. 8.17.3 Nestlé Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Nestlé Oral Nutraceutical Product Portfolio
  102. 8.17.5 Nestlé Recent Developments
  103. 8.18 Tate & Lyle
  104. 8.18.1 Tate & Lyle Company Information
  105. 8.18.2 Tate & Lyle Business Overview
  106. 8.18.3 Tate & Lyle Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Tate & Lyle Oral Nutraceutical Product Portfolio
  108. 8.18.5 Tate & Lyle Recent Developments
  109. 8.19 General Mills
  110. 8.19.1 General Mills Company Information
  111. 8.19.2 General Mills Business Overview
  112. 8.19.3 General Mills Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  113. 8.19.4 General Mills Oral Nutraceutical Product Portfolio
  114. 8.19.5 General Mills Recent Developments
  115. 8.20 Ingredion
  116. 8.20.1 Ingredion Company Information
  117. 8.20.2 Ingredion Business Overview
  118. 8.20.3 Ingredion Oral Nutraceutical Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Ingredion Oral Nutraceutical Product Portfolio
  120. 8.20.5 Ingredion Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst